https://www.selleckchem.com/pr....oducts/gsk2879552-2h
rs caused by active disease may put them off to be physically active. The benefits of chronic polytherapy in reducing readmissions and death after myocardial infarction (MI) have been clearly shown. However, real-world evidence shows poor medication adherence and large geographic variation, suggesting critical issues in access to optimal care. Our objectives were to measure adherence to polytherapy, to compare the amount of variation attributable to hospitals of discharge and to community-based providers, and to identify determi
Like
Comment
Share
